In addition, exploring the combined diagnostic strategy of GGT family molecules and traditional markers such as alpha fetoprotein (AFP) and PIVKA‐II may promote innovations in the precision diagnosis and treatment of HCC. This evidence concerns the gene GGTLC3 and hepatocellular carcinoma.